Blazejak, C., Oymanns, M., Stranzenbach, R., Hillen, U., Mitteldorf, C., Nicolay, J. P., . . . Assaf, C. (2025). Brentuximab vedotin in advanced-stage mycosis fungoides/Sézary syndrome with low CD30 expression: Real-world data from the German Cutaneous Lymphoma Network. Cancers, 18(1), . https://doi.org/10.3390/cancers18010097
Chicago-Zitierstil (17. Ausg.)Blazejak, Christoph, et al. "Brentuximab Vedotin in Advanced-stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-world Data from the German Cutaneous Lymphoma Network." Cancers 18, no. 1 (2025). https://doi.org/10.3390/cancers18010097.
MLA-Zitierstil (9. Ausg.)Blazejak, Christoph, et al. "Brentuximab Vedotin in Advanced-stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-world Data from the German Cutaneous Lymphoma Network." Cancers, vol. 18, no. 1, 2025, https://doi.org/10.3390/cancers18010097.